Tpg-Axon Management LP Stake In Centene Del (CNC) Was Boosted; Mckesson (MCK) Market Value Rose While Sector Gamma As Increased Position by $459,000

February 21, 2018 - By reb123z

Tpg-Axon Management Lp increased its stake in Centene Corp Del (CNC) by 49.7% based on its latest 2017Q3 regulatory filing with the SEC. Tpg-Axon Management Lp bought 24,500 shares as the company’s stock rose 11.03% with the market. The hedge fund held 73,800 shares of the medical specialities company at the end of 2017Q3, valued at $7.14M, up from 49,300 at the end of the previous reported quarter. Tpg-Axon Management Lp who had been investing in Centene Corp Del for a number of months, seems to be bullish on the $17.64 billion market cap company. The stock increased 1.45% or $1.45 during the last trading session, reaching $101.71. About 628,229 shares traded. Centene Corporation (NYSE:CNC) has risen 32.56% since February 21, 2017 and is uptrending. It has outperformed by 15.86% the S&P500.

Sector Gamma As increased its stake in Mckesson Corp (MCK) by 2.58% based on its latest 2017Q3 regulatory filing with the SEC. Sector Gamma As bought 3,000 shares as the company’s stock rose 1.84% with the market. The institutional investor held 119,100 shares of the other pharmaceuticals company at the end of 2017Q3, valued at $18.30 million, up from 116,100 at the end of the previous reported quarter. Sector Gamma As who had been investing in Mckesson Corp for a number of months, seems to be bullish on the $31.21B market cap company. The stock increased 1.63% or $2.42 during the last trading session, reaching $151.27. About 454,910 shares traded. McKesson Corporation (NYSE:MCK) has declined 15.45% since February 21, 2017 and is downtrending. It has underperformed by 32.15% the S&P500.

Investors sentiment decreased to 1.07 in 2017 Q3. Its down 0.14, from 1.21 in 2017Q2. It worsened, as 54 investors sold CNC shares while 174 reduced holdings. 83 funds opened positions while 160 raised stakes. 150.53 million shares or 0.42% less from 151.16 million shares in 2017Q2 were reported. Northwestern Mutual Wealth Management holds 363 shares or 0% of its portfolio. Commonwealth Of Pennsylvania School Empls Retrmt System holds 14,027 shares or 0.02% of its portfolio. Sumitomo Mitsui Asset reported 0.02% in Centene Corporation (NYSE:CNC). Los Angeles Mngmt & Equity Rech reported 197,718 shares. Jennison Associate Limited Liability Company holds 1.37M shares or 0.14% of its portfolio. Hillsdale Mgmt has 0.07% invested in Centene Corporation (NYSE:CNC) for 4,000 shares. Moreover, Cortland Associates Mo has 5.7% invested in Centene Corporation (NYSE:CNC) for 316,083 shares. Putnam Investments Ltd has invested 0% in Centene Corporation (NYSE:CNC). Mariner Wealth Advsr Ltd Llc stated it has 4,849 shares. Redmile Ltd Liability has invested 1.93% in Centene Corporation (NYSE:CNC). 17,046 were accumulated by Utd Cap Fincl Advisers Limited. Meiji Yasuda Life has invested 0.08% in Centene Corporation (NYSE:CNC). Gemmer Asset Mngmt Ltd has invested 0.02% of its portfolio in Centene Corporation (NYSE:CNC). Plante Moran Advisors Limited Liability Company reported 352 shares. Moreover, Veritable Lp has 0.01% invested in Centene Corporation (NYSE:CNC) for 2,576 shares.

Since October 26, 2017, it had 0 buys, and 3 selling transactions for $2.28 million activity. 10,000 Centene Corporation (NYSE:CNC) shares with value of $987,300 were sold by Hunter Jesse N.

Among 20 analysts covering Centene Corporation (NYSE:CNC), 16 have Buy rating, 1 Sell and 3 Hold. Therefore 80% are positive. Centene Corporation had 59 analyst reports since July 22, 2015 according to SRatingsIntel. Goldman Sachs upgraded Centene Corporation (NYSE:CNC) on Tuesday, December 13 to “Neutral” rating. As per Monday, December 18, the company rating was maintained by Wells Fargo. Cowen & Co maintained the shares of CNC in report on Monday, October 23 with “Buy” rating. Jefferies maintained the stock with “Buy” rating in Friday, January 12 report. The stock of Centene Corporation (NYSE:CNC) earned “Buy” rating by Jefferies on Wednesday, July 27. The stock has “Buy” rating by Cantor Fitzgerald on Tuesday, October 24. Stifel Nicolaus upgraded the shares of CNC in report on Thursday, May 26 to “Buy” rating. The stock has “Sell” rating by Goldman Sachs on Wednesday, July 22. The firm has “Buy” rating by Cantor Fitzgerald given on Thursday, December 14. Credit Suisse downgraded the shares of CNC in report on Friday, November 11 to “Neutral” rating.

Among 22 analysts covering McKesson Corporation (NYSE:MCK), 12 have Buy rating, 1 Sell and 9 Hold. Therefore 55% are positive. McKesson Corporation had 79 analyst reports since July 31, 2015 according to SRatingsIntel. The stock of McKesson Corporation (NYSE:MCK) has “Neutral” rating given on Friday, October 28 by Robert W. Baird. Mizuho maintained McKesson Corporation (NYSE:MCK) rating on Thursday, February 1. Mizuho has “Hold” rating and $179.0 target. Leerink Swann maintained the stock with “Hold” rating in Monday, April 24 report. Mizuho maintained McKesson Corporation (NYSE:MCK) on Friday, January 15 with “Buy” rating. The company was downgraded on Friday, November 11 by Standpoint Research. The company was maintained on Wednesday, January 24 by Mizuho. The stock of McKesson Corporation (NYSE:MCK) earned “Buy” rating by S&P Research on Friday, July 31. Cowen & Co upgraded the shares of MCK in report on Tuesday, October 10 to “Outperform” rating. The stock of McKesson Corporation (NYSE:MCK) earned “Buy” rating by Jefferies on Wednesday, January 24. The stock has “Outperform” rating by Robert W. Baird on Tuesday, September 19.

Sector Gamma As, which manages about $656.08M US Long portfolio, decreased its stake in Gilead Sciences Inc (NASDAQ:GILD) by 212,700 shares to 335,690 shares, valued at $27.20M in 2017Q3, according to the filing. It also reduced its holding in Shire Plc (NASDAQ:SHPG) by 45,705 shares in the quarter, leaving it with 162,156 shares, and cut its stake in Bio Rad Labs Inc (NYSE:BIO).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.